News

Filter

Current filters:

Boehringer Ingelheim

151 to 160 of 97537 results

Amgen to collaborate with University of Texas on BiTE technology

Amgen to collaborate with University of Texas on BiTE technology

13-01-2015

US biotech major Amgen is to collaborate with the MD Anderson Cancer Center at the University of Texas…

AmgenBiotechnologyOncologyResearchUSA

New drugs and biosimilars to drive rheumatoid arthritis to $19.3 billion by 2023

New drugs and biosimilars to drive rheumatoid arthritis to $19.3 billion by 2023

13-01-2015

The launch of novel drugs and biosimilars will drive steady growth in the global rheumatoid arthritis…

AmgenAnti-Arthritics/RheumaticsEnbrelHumiraMarkets & MarketingPharmaceuticalResearchUSA

Merck & Co updates on plans to accelerate new drug submissions and future growth

Merck & Co updates on plans to accelerate new drug submissions and future growth

13-01-2015

US pharma giant Merck & Co has reported on the ongoing execution of its multi-year, strategic initiative…

Anti-viralsgrazoprevir/elbasvirKeytrudaMerck & CoOncologyPharmaceuticalRegulationResearchUSA

Harvoni scores another victory with inclusion on Prime’s preferred list

Harvoni scores another victory with inclusion on Prime’s preferred list

13-01-2015

US pharmacy Prime Therapeutics has agreed to provide hepatitis C drug Harvoni (ledipasvir/sofosbuvir)…

Antibiotics and Infectious diseasesBiotechnologyGileadHarvoniPricingUSA

Debiopharm regains rights to alisporivir in hepatitis C from Novartis

Debiopharm regains rights to alisporivir in hepatitis C from Novartis

13-01-2015

Switzerland-based biopharma company Debiopharm has updated its arrangement with Novartis to regain full…

alisporivirDebiopharmLicensingNephrology and HepatologyNovartisPharmaceuticalResearch

AMRI to develop parenteral drug products with Genovi

13-01-2015

Albany Molecular Research has entered into several development and supply agreements with the UK’s…

Albany Molecular ResearchEuropeGenericsGenovi PharmaceuticalsMarkets & MarketingProductionUSA

UCB appoints Jean-Christophe Tellier as chief executive

UCB appoints Jean-Christophe Tellier as chief executive

13-01-2015

Belgian drugmaker UCB has replaced chief executive Roch Doliveux with Jean-Christophe Tellier.

BelgiumBoardroomJean-Christophe TellierPharmaceuticalUCB

151 to 160 of 97537 results

Back to top